Ligufalimab (Anti-CD47) | CD markers antibody | Read Reviews & Product Use Citations

Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.

Purity & Quality Control

Batch: A282501 Purity: 99% Protein concentration: 8.58mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.

References
[1] Qu T, et al. J Immunother Cancer. 2022;10(11):e005517.

References

[1] Qu T, et al. J Immunother Cancer. 2022;10(11):e005517.

Product Details

CAS No.	2428381-55-7
Molecular Weight	144.58
Isotype	Human IgG4SP
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field